The Committee will review the draft risk management evaluation on pentachlorophenol and its salts and esters, draft risk profile on decabromodiphenyl ether, and the proposal for listing dicofol in Annex A, B, and/or C to the Stockholm Convention. The Committee will also consider the draft reports prepared for the evaluation of perfluorooctane sulfonic acid, its salts and perfluorooctane sulfonyl fluoride pursuant to paragraphs 5 and 6 of part III of Annex B to the Stockholm Convention.